Cluster4Future CNATM now online

Aug 04, 2023

The website of our Clusters4Future Cluster for Nucleic Acid Therapeutics Munich - CNATM with headquarters at our Faculty of Chemistry and Pharmacy is now online:

The following scientists* are involved in CNATM at our faculty: Olivia Merkel, Sabine Schneider, Franziska Traube, Oliver Baron, Thomas Carell, Pascal Giehr, Karl-Peter Hopfner, Veit Hornung, Pavel Kielkowski, Philip Tinnefeld and Ernst Wagner.

CNATM is one of seven winners (the only one in Bavaria) of the second round of the Clusters4Future initiative of the German Federal Ministry of Education and Research.

The cluster forms an innovation network of science and industry, which is funded with five million euros annually by the federal government, the Free State of Bavaria and participating companies. The research network consists of scientists from the leading universities LMU Munich and TUM. With the participation of the universities of Regensburg and Würzburg, the Helmholtz Center Munich and 17 companies from the region around Munich.

A total of 22 applications were awarded funding, marking the start of the Nucleic Acid Isar Valley.

The multilateral collaborations of CNATM are creating a network from which novel nucleic acid-based drugs and next-generation vaccines will be developed.

Recent discoveries give rise to the hope that the ability to design nucleic acids in a highly specific and theoretically predictable way will open up completely new therapeutic approaches in medicine and thus help many people.

There is no substance class that is better suited to personalized medicine than nucleic acids. The Cluster4Future wants to help nucleic acid therapies achieve a breakthrough and thus make a contribution that makes sense: curing people and creating jobs in and around Munich.